Clinical In Vivo Gene Therapy

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Children bear a disproportionate burden of genetic disease. Gene-based therapies are rapidly evolving to provide disease altering and potentially curative therapeutic options. The Clinical In Vivo Gene Therapy group (CIGT) is dedicated to developing and conducting adeno-associated virus gene transfer and molecular therapy trials at Children’s Hospital of Philadelphia. Through industry partnerships and investigator-initiated trials, CIGT seeks to further the development of transformative human therapies and to build upon CHOP’s legacy as a leader in gene therapy research.

Led by experts in in vivo gene therapy research, with more than 10 years of clinical trial experience, the CIGT team has a wealth of knowledge to navigate the complex safety, regulatory, and clinical care considerations of gene therapy clinical research. Our group offers resources to support the startup and conduct of industry-sponsored trials, as well as regulatory and clinical operations support for CHOP investigator-initiated clinical trials.

Grant Funds Gene Therapy Development for Metabolic Diseases

Grant Funds Gene Therapy Development for Metabolic Diseases
Researchers are creating a platform to help fast-track personalized gene-editing therapies for patients with urea cycle disorders.
Read More

For CHOP investigators wishing to translate their own research into the clinic, CIGT can help facilitate continuity among the various groups involved in the translational process (e.g., the Clinical Vector Core or Cell and Gene Therapy Laboratory).

CIGT [at] chop.edu (Clinical In Vivo Gene Therapy Services)

Clinical In Vivo Gene Therapy Services

The Clinical In Vivo Gene Therapy group offers services to support the development and conduct of in vivo gene and molecular therapy trials at CHOP, as well as the implementation of these novel molecular therapies into the clinic post licensure:

  • Scientific advice from experienced gene therapy clinician researchers who are available to review, assess, and advise on industry and investigator proposed trials
  • Centralized clinical research coordinator support for industry-sponsored study startup and trial conduct
  • Regulatory affairs support for study design and the IND submission.

Please CIGT [at] chop.edu (contact us) to see how we can help support your clinical in vivo gene therapy study.

CIGT [at] chop.edu (Contact Us)
Leader
Lindsey A. George

Lindsey A. George, MD